Access to alcohol among middle school children New research shows that if parents want to keep alcohol away from their middle school children, the best place to start reaches home. The study, reported in the June issue of Preventive Medicine, implies that of 11-14 season olds who choose to drink, only a small fraction get alcohol from commercial venues. More than one-third of the alcoholic beverages consumed by these kids came from their own or a friend’s parents or guardians CialisPrix.Net . The proportion of alcohol users can be disturbing; 17 percent in the beginning of the 6th grade and a lot more than doubly many, 41 percent by the finish of the 8th grade. The analysis reminds parents that they need to consider their positions as role models at the key time when their middle school children are likely to have their first severe encounters with alcoholic beverages. Between 2002 and 2005, Principal Investigator Kelli Komro, lead author Mary O colleagues and Hearst studied a cohort of 3,709 students, mainly of Hispanic and African-American backgrounds, who had been surveyed in 58 Chicago public colleges at the end and start of the 6th, 7th, and 8th grades. The analysis is unique as no other study has followed young, racially diverse, poor urban youth over a two and a half year period, observing patterns of social and commercial alcohol access this way. ‘Early onset of drinking leads to a long list of alcohol-related problems. It is important to educate parents about the consequences of alcohol make use of at a age and try to prevent them from becoming their child’s primary way to obtain alcohol.’ comments the business lead author. FALP can be the first hospital in Latin America to set up both Accuray systems. The gadgets provide a noninvasive treatment choice and are used world-wide for delivering specific radiation therapy while maximizing patients' standard of living after and during treatment. The radiation therapy group at FALP expects to begin with treating patients in the first one fourth of 2016. Government officials, including Chilean President Michelle Bachelet, will attend FALP's opening ceremony today in support of the institute's commitment to becoming an international leader in the prevention, detection and treatment of cancer. The nonprofit institute is dedicated to providing the best treatment possible regardless of a person's economic status also to supporting families with socioeconomic vulnerability. ‘Our objective at FALP is to supply each cancer individual with high-quality treatments tailored to their individual requirements,’ stated Dr. Hugo Marsiglia, radiation oncologist and medical director at FALP Cancer Institute in Santiago.’ The CyberKnife M6 Series delivers radiosurgery and stereotactic body radiation therapy , enabling precise, high-quality dose distributions to be delivered confidently to the individual with extreme accuracy over the very least number of remedies, reducing side effects and preserving individuals' quality of life. The system accounts for patient and tumor motion by adjusting instantly in real-time, ensuring on-focus on delivery of radiation. CyberKnife is the only robotic radiosurgery system available today which delivers such high precision treatments for intra – and extra-cranial disease sites throughout the body including the prostate, lung, brain, spine, liver, pancreas and kidney. Related StoriesNew findings reveal association between colorectal cancers and melanoma medication treatmentNew RNA test of blood platelets can be used to detect location of cancerNew antenna-like device makes breast cancer medical procedures easier for surgeons’Working with the FALP group to bring the innovative radiation therapy answers to the folks of Chile represents our commitment to increasing usage of our technology all over the world,’ said Joshua H. Levine, president and ceo of Accuray. ‘With the CyberKnife and TomoTherapy Systems, FALP has the ability to significantly and positively effect the way cancer is managed, and bring new hope to people who would in any other case be without options.’ The TomoTherapy System may be the only radiation program specifically designed for image-guided intensity-modulated radiation therapy . Predicated on a CT scanner platform, the operational program provides constant delivery of radiation from 360 degrees around the individual, or delivery from clinician-specified beam angles. These unique features, coupled with daily 3D picture guidance, enable physicians to deliver highly accurate, individualized dosage distributions which precisely conform to the shape of the patient's tumor even though minimizing dose to normal, healthy tissue, resulting in fewer unwanted effects for patients.